On March 19, 2026, the research team led by Professor Qian Feng from the School of Pharmaceutical Sciences, Tsinghua University, collaborated with the Beijing Institute of Vision Science and Translational Ophthalmology to publish a review titled Biologics-device combinations: Enabling prolonged therapies in the posterior segment ocular disease in the top international journal Advanced Drug Delivery Reviews. This review systematically summarizes the cutting-edge global delivery technologies of biologics-device combinations, outlining a clear roadmap for ultra-long-acting ophthalmic treatment with administration intervals ranging from several months to years.
